Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor

K Brummel-Ziedins1, A Undas, T Orfeo

  • 1Department of Biochemistry, University of Vermont, VT 05446, USA. kathleen.brummel@uvm.edu

Insights

Thrombin generation profiles, based on circulating coagulation proteins, can differentiate acute coronary syndrome (ACS) from stable coronary artery disease (CAD). This finding aids in distinguishing between these critical cardiovascular conditions.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Background:

  • Acute coronary syndrome (ACS) involves thrombin formation from ruptured atheroma.
  • Distinguishing ACS from stable coronary artery disease (CAD) is clinically important.
  • Circulating coagulation protein levels may serve as biomarkers.

Purpose of the Study:

  • To investigate if thrombin generation profiles can differentiate between ACS and stable CAD.
  • To assess the role of specific coagulation factors in thrombin generation.

Main Methods:

  • Collected plasma coagulation factor compositions from ACS and stable CAD patients.
  • Assessed tissue factor-initiated thrombin generation computationally and empirically.
  • Excluded patients on anticoagulant therapy.

Main Results:

  • Significant differences in antithrombin (AT), factor II (FII), factor VIII (FVIII), and tissue factor pathway inhibitor (TFPI) levels were observed.
  • ACS patients exhibited higher FII, FVIII, TFPI, and lower AT levels.
  • Simulated thrombin generation was 50% higher and initiated faster in ACS patients.

Conclusions:

  • Simulations of thrombin generation based on plasma composition can discriminate between acute and stable CAD.
  • Coagulation factors AT, FII, and FVIII are key determinants of these differences.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...